Follow
Ailsa Sita-Lumsden
Ailsa Sita-Lumsden
consultant medical oncologist
Verified email at gstt.nhs.uk
Title
Cited by
Cited by
Year
Androgen-regulated processing of the oncomir miR-27a, which targets Prohibitin in prostate cancer
CE Fletcher, DA Dart, A Sita-Lumsden, H Cheng, PS Rennie, CL Bevan
Human molecular genetics 21 (14), 3112-3127, 2012
235*2012
Reactivation of tuberculosis and vitamin D deficiency: the contribution of diet and exposure to sunlight
A Sita-Lumsden, G Lapthorn, R Swaminathan, HJ Milburn
Thorax 62 (11), 1003-1007, 2007
1862007
Circulating microRNAs as potential new biomarkers for prostate cancer
A Sita-Lumsden, DA Dart, J Waxman, CL Bevan
British journal of cancer 108 (10), 1925-1930, 2013
1812013
Treatment outcomes for 618 women with gestational trophoblastic tumours following a molar pregnancy at the Charing Cross Hospital, 2000–2009
A Sita-Lumsden, D Short, I Lindsay, NJ Sebire, D Adjogatse, MJ Seckl, ...
British journal of cancer 107 (11), 1810-1814, 2012
1682012
The relationship of maternal age to molar pregnancy incidence, risks for chemotherapy and subsequent pregnancy outcome
PM Savage, A Sita-Lumsden, S Dickson, R Iyer, J Everard, R Coleman, ...
Journal of Obstetrics and Gynaecology 33 (4), 406-411, 2013
1362013
Revising the role of the androgen receptor in breast cancer
FM Fioretti, A Sita-Lumsden, CL Bevan, GN Brooke
Journal of molecular endocrinology 52 (3), R257-R265, 2014
1132014
Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective …
DJ Pinato, J Tabernero, M Bower, L Scotti, M Patel, E Colomba, S Dolly, ...
The Lancet Oncology 22 (12), 1669-1680, 2021
1082021
Factors affecting COVID-19 outcomes in cancer patients: a first report from guy's cancer center in London
B Russell, C Moss, S Papa, S Irshad, P Ross, J Spicer, S Kordasti, ...
Frontiers in oncology 10, 1279, 2020
702020
Time-dependent COVID-19 mortality in patients with cancer: an updated analysis of the OnCovid registry
DJ Pinato, M Patel, L Scotti, E Colomba, S Dolly, A Loizidou, J Chester, ...
JAMA oncology 8 (1), 114-122, 2022
652022
Amplification-free detection of circulating microRNA biomarkers from body fluids based on fluorogenic oligonucleotide-templated reaction between engineered peptide nucleic acid …
GAD Metcalf, A Shibakawa, H Patel, A Sita-Lumsden, A Zivi, N Rama, ...
Analytical chemistry 88 (16), 8091-8098, 2016
582016
Outcomes of the SARS-CoV-2 omicron (B. 1.1. 529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre …
DJ Pinato, D Ferrante, G Hanbury, M Bower, R Salazar, O Mirallas, ...
The Lancet Oncology 23 (7), 865-875, 2022
562022
Risk of COVID-19 death in cancer patients: an analysis from Guy’s Cancer Centre and King’s College Hospital in London
B Russell, CL Moss, V Shah, TK Ko, K Palmer, R Sylva, G George, ...
British journal of cancer 125 (7), 939-947, 2021
522021
Uterine artery pulsatility index improves prediction of methotrexate resistance in women with gestational trophoblastic neoplasia with FIGO score 5–6
A Sita‐Lumsden, H Medani, R Fisher, R Harvey, D Short, N Sebire, ...
BJOG: An International Journal of Obstetrics & Gynaecology 120 (8), 1012-1015, 2013
482013
Regression of melanoma metastases following treatment with the n-bisphosphonate zoledronate and localised radiotherapy
U Laggner, JS Lopez, G Perera, VS Warbey, A Sita-Lumsden, ...
Clinical Immunology 131 (3), 367-373, 2009
482009
Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score
GM Dettorre, S Dolly, A Loizidou, J Chester, A Jackson, U Mukherjee, ...
Journal for ImmunoTherapy of Cancer 9 (3), 2021
422021
Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study
DJ Pinato, L Scotti, A Gennari, E Colomba-Blameble, S Dolly, A Loizidou, ...
European Journal of Cancer 150, 190-202, 2021
402021
Reducing prohibitin increases histone acetylation, and promotes androgen independence in prostate tumours by increasing androgen receptor activation by adrenal androgens
DA Dart, GN Brooke, A Sita-Lumsden, J Waxman, CL Bevan
Oncogene 31 (43), 4588-4598, 2012
312012
Circulating nucleic acids as biomarkers of prostate cancer
A Sita-Lumsden, CE Fletcher, DA Dart, GN Brooke, J Waxman, CL Bevan
Biomarkers in medicine 7 (6), 867-877, 2013
292013
Demographics, natural history and treatment outcomes of non‐molar gestational choriocarcinoma: a UK population study
P Savage, M Winter, V Parker, V Harding, A Sita‐Lumsden, RA Fisher, ...
BJOG: An International Journal of Obstetrics & Gynaecology 127 (9), 1102-1107, 2020
232020
COVID-19 sequelae and the host proinflammatory response: an analysis from the OnCovid registry
A Cortellini, A Gennari, F Pommeret, G Patel, T Newsom-Davis, A Bertuzzi, ...
JNCI: Journal of the National Cancer Institute 114 (7), 979-987, 2022
202022
The system can't perform the operation now. Try again later.
Articles 1–20